Selected agents targeting the Fyn/CD133/PI3K/Akt/mTOR pathway
Selected agents targeting the Fyn/CD133/PI3K/Akt/mTOR pathway. Fyn, PI3KAKT, mTORC1, and mTORC1/mTORC2 inhibitors
Publication
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance (2024) Naji Kharouf, et al. Cells. 2024 Feb;13(3). Figure: F10.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | CD133 | CD133 | ncbigene_synonym | PROM1 | 8842 |
| Homo sapiens | Primates | Fyn | FYN | ncbigene_symbol | FYN | 2534 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | ARHGEF7 | 8874 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | CBFA2T2 | 9139 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | PPP1R13B | 23368 |
| Homo sapiens | Primates | P85 | P85 | ncbigene_synonym | PPP1R12C | 54776 |
| Homo sapiens | Primates | P110ẞ | P110 | ncbigene_synonym | CUX1 | 1523 |
| Homo sapiens | Primates | P110ẞ | P110 | ncbigene_synonym | SART3 | 9733 |
| Homo sapiens | Primates | PI(4,5)P2 | PI4 | ncbigene_synonym | SERPINA4 | 5267 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | TSCI/TSC2 | TSC2 | ncbigene_symbol | TSC2 | 7249 |
| Homo sapiens | Primates | ERM | ERM | ncbigene_synonym | ETV5 | 2119 |
| Homo sapiens | Primates | ERM | ERM | famplex_relations | EZR | 7430 |
| Homo sapiens | Primates | ERM | ERM | famplex_relations | RDX | 5962 |
| Homo sapiens | Primates | ERM | ERM | famplex_relations | MSN | 4478 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MAPKAP1 | 79109 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | RICTOR | 253260 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MLST8 | 64223 |
| Homo sapiens | Primates | mTORC1 | MTORC1 | famplex_relations | RPTOR | 57521 |
| Homo sapiens | Primates | Rheb | RHEB | ncbigene_symbol | RHEB | 6009 |
| Homo sapiens | Primates | Rheb | RHEB | ncbigene_synonym | RHEBP1 | 6008 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| PI3K inhibitors | PI3K inhibitors | chebi:50914 | ||
| XL-765 | XL-765 | N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide | chebi:71958 | |
| Everolimus | everolimus | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:68478 | |
| Fyn inhibitors | FYN inhibitors | chebi:76617 | ||
| Saracatinib | saracatinib | N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine | chebi:47458 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|